Items where authors include "Gibani, M."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Oguti, B., Gibani, M., Darlow, C. et al. (7 more authors) (2019) Factors influencing participation in controlled human infection models : a pooled analysis from six enteric fever studies [under peer review]. Wellcome Open Research, 4. 153.

Blohmke, C., Muller, J. orcid.org/0000-0002-1046-2968, Gibani, M. et al. (15 more authors) (2018) Diagnostic host gene signature to accurately distinguish enteric fever from other febrile diseases. BioRxiv. (Submitted)

Darton, T.C. orcid.org/0000-0003-2209-9956, Jones, C., Dongol, S. et al. (12 more authors) (2017) Assessment and Translation of the Antibody-in-Lymphocyte Supernatant (ALS) Assay to Improve the Diagnosis of Enteric Fever in Two Controlled Human Infection Models and an Endemic Area of Nepal. Frontiers in Microbiology, 8. 2031.

Meiring, J.E., Gibani, M., Basnyat, B. et al. (23 more authors) (2017) The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK. Vaccine, 35 (38). pp. 5081-5088. ISSN 0264-410X